SPINT2 antibody (C-Term)
Quick Overview for SPINT2 antibody (C-Term) (ABIN1590088)
Target
See all SPINT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- C-Term
-
Purpose
- SPINT2
-
Sequence
- SGDDKEQLVK NT
-
Specificity
- This antibody is expected to recognize to recognize both reported isoforms (NP_066925.1, NP_001159575.1).
-
Cross-Reactivity
- Cow, Dog, Human, Mouse, Rat
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: Approx 20 kDa band observed in Human Placenta lysates (calculated MW of 21.8 kDa according to NP_001159575.1). Recommended concentration: 1-3 μg/mL. Primary incubation 1 hour at room temperature.
Peptide ELISA: antibody detection limit dilution 1:1000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- SPINT2 (serine Peptidase Inhibitor, Kunitz Type, 2 (SPINT2))
-
Alternative Name
- SPINT2
-
Background
- SPINT2, serine peptidase inhibitor, Kunitz type, 2, DIAR3, FLJ45571, HAI-2, HAI2, Kop, PB, hepatocyte growth factor activator inhibitor type 2, placental bikunin, serine protease inhibitor, Kunitz type, 2
-
Gene ID
- 10653, 20733, 292770
-
NCBI Accession
- NP_066925, NP_001159575
Target
-